FDA Approved: PROVAYBLUE — Original Application (American Regent, Inc.)

View source ↗

Summary

ProvayBlue (methylene blue) received FDA approval through an original new-drug application. It is indicated for the treatment of methemoglobinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methemoglobinemia

Drugs mentioned

• PROVAYBLUE (METHYLENE BLUE)

Snippet

ORIG AP for PROVAYBLUE (METHYLENE BLUE)